Duzova, A <br/><br/>
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.  [electronic resource] 

 -  Transplantation proceedings  Dec 2003 
 - 2878-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2003.10.087  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Basiliximab<br/>Child<br/>Cyclosporine--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Graft Rejection--epidemiology<br/>Graft Survival--physiology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Male<br/>Mycophenolic Acid--analogs & derivatives<br/>Recombinant Fusion Proteins<br/>Survival Analysis<br/>Tacrolimus--therapeutic use<br/>Time Factors